United Guardian Inc (UG) Stock Price & Analysis
United Guardian Inc (UG) rose 0.87% to USD 6.96 as of June 10, 2026 at 09:17 UTC, according to Nexqual real-time market data.
UG last closed at USD 6.9; the session ranged USD 6.91–7.06 on volume of 2,257 shares. Market capitalization is $31.98M, with a 52-week range of USD 5.58–9.88 (NGM). Source: Nexqual, June 10, 2026 at 09:17 UTC.
Key Statistics (as of June 10, 2026 at 09:17 UTC)
| Price | USD 6.96 |
|---|---|
| Change | ▲ 0.87% (up) |
| Previous Close | USD 6.9 |
| Open | USD 6.91 |
| Day Range | USD 6.91 – 7.06 |
| 52-Week Range | USD 5.58 – 9.88 |
| Volume | 2,257 shares |
| Market Cap | $31.98M |
| Exchange | NGM |
Technical Analysis (UG)
Nexqual's technical model rates UG "SELL" based on 2 bullish and 4 bearish signals across 123 daily candles, as of June 10, 2026 at 09:17 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 47.9 (neutral) |
| vs SMA50 | Above (USD 6.9) |
| MACD | 0.01 (positive) |
Analyst Ratings (UG)
Wall Street analysts rate UG "None", per Nexqual as of June 10, 2026 at 09:17 UTC.
| Consensus Rating | None |
|---|
Earnings (UG)
Source: Nexqual, June 10, 2026 at 09:17 UTC.
Financials & Fundamentals (UG)
| Total Revenue | $10.94M |
|---|---|
| Revenue Growth (YoY) | +15.80% |
| Gross Margin | +47.62% |
| Operating Margin | +22.37% |
| Profit Margin | +21.61% |
| ROE | +21.75% |
| Current Ratio | 8.05 |
| Total Cash | $8.04M |
| Total Debt | $0 |
| Free Cash Flow | $802,758 |
Source: Nexqual, June 10, 2026 at 09:17 UTC.
Financial Health Score (UG)
Nexqual rates United Guardian Inc's overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 09:17 UTC.
| Growth | Strong — Revenue +16% YoY (latest Q) |
|---|---|
| Profitability | Weak — Small revenue base — building scale |
| Balance Sheet | Mixed — $8M cash, no debt |
| Cash Flow | Solid — FCF $803K, 7% margin |
| Efficiency | Strong — ROE 22%, ROA 11.2% |
Ownership (UG)
| Insider Ownership | +35.85% |
|---|---|
| Institutional Ownership | +20.79% |
| Shares Outstanding | 4.59M |
| Float | 2.90M |
| Short % of Float | +0.30% |
Source: Nexqual, June 10, 2026 at 09:17 UTC.
Leadership (UG)
United Guardian Inc is led by Donna Vigilante (age 44), President & Director, per Nexqual as of June 10, 2026 at 09:17 UTC.
| President & Director | Donna Vigilante (age 44) |
|---|---|
| CFO, Treasurer, Controller, Secretary & Human Resources Manager | Andrea J. Young (age 56) |
| Marketing Director | Denise Costrini |
Major Backers & Investors (UG)
Notable institutional backers of United Guardian Inc include Renaissance Technologies, Gamco Investors, Inc ET AL, EQ Advisors Trust-1290 VT GAMCO Small Company Value Portfolio, according to Nexqual as of June 10, 2026 at 09:17 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Renaissance Technologies | 3.83% |
| Gamco Investors, Inc ET AL | 3.58% |
| EQ Advisors Trust-1290 VT GAMCO Small Company Value Portfolio | 3.41% |
| Rodgers Brothers Inc. | 1.38% |
| Teton Advisors, LLC | 1.17% |
| Teton Westwood Funds-TETON WESTWOOD MIGHTY MITES FUND | 1.17% |
| Parthenon LLC | 1.1% |
| DFA INVESTMENT DIMENSIONS GROUP INC-U.S. Micro Cap Portfolio | 0.88% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 5.53% |
| Dimensional Fund Advisors | 1.72% |
Source: Nexqual, June 10, 2026 at 09:17 UTC.
From United Guardian Inc's Latest SEC 10-K Filing (filed 2026-03-27)
Key Strengths & Strategy (as disclosed to the SEC)
- United-Guardian, Inc. develops, manufactures, sells, and markets specialty cosmetic ingredients, pharmaceutical products, medical lubricants, and sexual wellness ingredients in the United States and internationally.
- The company offers cosmetic ingredients, including LUBRAJEL, a line of multifunctional hydrogel formulations for personal care and medical products; B-122, a powdered lubricant used in the manufacture of certain cosmetics, such as pressed powders, eyeliners, and rouges, as well as some industrial products; ORCHID COMPLEX, an oil-based extract of orchids; and LUBRASIL II SB, a special formulation of Lubrajel in which silicone oil incorporates into a Lubrajel base.
- It also provides medical lubricant products for catheter lubrication, medical devices, condom lubrication, and oral care under the Lubrajel brand, including Lubrajel MG, Lubrajel MGL, Lubrajel RRCG, Lubrajel RR, Lubrajel RC, Lubrajel RA, Lubrajel Fluid, Lubrajel LC, Lubrajel BA, and Lubrajel FACO.
- In addition, the company offers pharmaceutical products comprising RENACIDIN, a prescription to prevent and to dissolve calcifications in urethral catheters; and CLORPACTIN WCS-90, a chlorine-based drug, which is a topical antimicrobial and is also used in urology.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| UTMD | Utah Medical Products, Inc. | USD 68.07 | ▲ 0.62% |
| UNB | Union Bankshares, Inc. | USD 23.48 | ▲ 0.95% |
| NAII | Natural Alternatives Internatio | USD 2.51 | ▲ 0.2% |
| WEYS | Weyco Group, Inc. | USD 35.92 | ▲ 2.39% |
| UBCP | United Bancorp, Inc. | USD 16.34 | ▲ 2.77% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 09:17 UTC. This page is informational and not investment advice.